3 hours Sage Therapeutics (NASDAQ:SAGE) PT Lowered to $9.00 at Robert W. Baird MarketBeat
Robert W. Baird lowered their target price on Sage Therapeutics from $13.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday.